Success Stories: Our Team Successfully Obtained NIW and EB1A Approval for a Chinese Associate Professor in the Field of Pathogenic Biology
Client’s Testimonial:
“I really appreciate your great help in the process of my case. I think my EB1A case will also be smooth like my NIW case (which was approved in only 1 month with no PP). Thank you so much again.”
On April 13th, 2023 and February 21st, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) Approval for an Associate Professor in the Field of Pathogenic Biology (Approval Notice).
General Field: Pathogenic Biology
Position at the Time of Case Filing: Associate Professor
Country of Origin: China
Country of Residence at the Time of Filing: China
Approval Notice Date: April 13th, 2023 (NIW) and February 21st, 2024 (EB1A)
Processing Time: 1 month (NIW) and 10 months (EB1A)
Case Summary:
Our client, an associate professor in the field of pathogenic biology, holds a Ph.D. in pathogenic organisms. She first approached the North America Immigration Law Group for her NIW (National Interest Waiver) petition. She mailed us her credentials, which our knowledgeable attorneys examined thoroughly, and customized her NIW petition to meet the specific requirements.
We began by highlighting her remarkable work that has been fundamental to studying the interaction between bacteria and host. She has made significant original contributions to the field of pathogenic biology, addressing some of the nation's and the world's most pressing issues, including severe bacterial infections.
In March 2023, we submitted her NIW petition to USCIS, which was approved in just one month without the need for a premium processing upgrade, a great achievement.
Impressed by our efforts on her NIW petition, a month after its approval, our client hired us again to file an I-140 EB1A (Alien of Extraordinary Ability) visa petition. Our client's exceptional scientific background made her an ideal candidate for this visa, and we discussed her 35 peer-reviewed scientific articles published in high-impact journals in the field, earning a combined 1,068 citations. These publications demonstrate the impact she has had on her peers and colleagues in the field.
Also, she has completed 30 peer reviews, demonstrating her active and genuine participation in evaluating the work of other pathogenic biology specialists.
Moreover, our client has received recognition and funding support from various major organizations, including the National Natural Science Foundation of China (NSFC) and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), which serves as evidence that her work is important to the international pathogenic biology community.
When we submitted documentation of our client's research and letters of recommendation from renowned professionals in her field, attesting to her exceptional research abilities, she received her EB1A approval without any RFE issuance.
Experts agree that her continued participation is critical to the overall success of bacterial infection treatment in the field of pathogenic biology. Therefore, her past and current achievements suggest that she will continue to provide substantial benefits to the United States. We are delighted to have provided USCIS with all the relevant information regarding our client's research and to receive two wonderful approval stories (NIW and EB1A) in a row. We wish our client all the best in her future endeavors.